Drug
Tebentafusp Tebn
Tebentafusp Tebn: highest development phase Phase 2, developed by Immunocore. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Immunocore
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tebentafusp-Tebn NCT06414590 | Phase 2 | Locally Advanced Unresectable Uveal Melanoma |
Latest
No recent events.
Follow Tebentafusp Tebn on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.